Product Images Zykadia

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Zykadia NDC 0078-0694 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The chemical structure of ceritinib is Ceritinib is a white to almost white or light yellow or light brown powder with a pKa of 9.7 and 4.1. - zykadia 01

The chemical structure of ceritinib is Ceritinib is a white to almost white or light yellow or light brown powder with a pKa of 9.7 and 4.1. - zykadia 01

Figure 1: Kaplan-Meier Plot of Progression-Free Survival as Assessed by BIRC by Treatment Arm in ASCEND-4 - zykadia 02

Figure 1: Kaplan-Meier Plot of Progression-Free Survival as Assessed by BIRC by Treatment Arm in ASCEND-4 - zykadia 02

PRINCIPAL DISPLAY PANELBottle Label – 150 mgRx Only NDC 0078-0640-70Zykadia (ceritinib) capsules 150 mg70 Capsules - zykadia 03

PRINCIPAL DISPLAY PANELBottle Label – 150 mgRx Only		NDC 0078-0640-70Zykadia (ceritinib) capsules 150 mg70 Capsules - zykadia 03

This text is a medication label for tablets containing 150mg of eritinib, with dosage information included in the prescribing information. The medication is called Zykadia and is manufactured by Novartis Pharma in Switzerland. The tablets should be stored at controlled room temperature and kept out of reach of children. This is a prescription medication and should be used as directed.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.